About This Stock More About This StockReadReadReadRead
Article By: The Fly
Wednesday, January 11, 2017 11:50 AM EST
Shares of Merck are on the rise after the company announced the Food and Drug Administration has accepted for priority review its application for its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer.
Article By: David Fabian
Thursday, January 5, 2017 5:02 AM EST
Over the last twelve months, the Health Care Select Sector SPDR posted a total return of -2.76%. That final performance includes dividends and carries the stigma of being the only major S&P sector to finish the year in negative territory.